360° SearchNetwork Hot Spots Trends Time Series

Advair

Type: Product

Name: Advair

First reported May 24 2013 - Updated May 25 2013 - 2 reports

To Your Good Health: Are asthma meds, high blood pressure linked?

Dear Dr. Roach: I use Advair every day, two times a day, and I now have high blood pressure. I have heard there is a connection between the two. What can be done about it? Will this be a long-term problem? Thanks. â E.G.A: Advair is a combination inhaled ... [Published Herald & Review - May 25 2013]

Entities: Hypertension, Bronchodilator, Advair

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Survey indicates improved effect on quality of life is one of the greatest unmet needs of COPD patients

Decision Resources : 22 May, 2013 (Company News)Decision Resources finds that surveyed US and European pulmonologists agree that therapies offering a greater effect on quality of life is among the areas of highest unmet need.Decision Resources finds ... [Published Pro Health Service Zone - May 22 2013]

Entities: Glycopyrronium, Chronic Obstructive Pulmonary Disease, Decision Resources Group

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Research and Markets Offers Report: Inhalation & Nasal Spray Generic Drugs 2012 [Professional Services Close - Up]

Research and Markets has announced the addition of the "Inhalation & Nasal Spray Generic Drugs 2012" report to its offerings.In a release, Research and Markets noted that report highlights include:It is no surprise then, that such high revenue originator ... [Published Pharmacy Choice - May 14 2013]

Entities: Inhalation, Seretide, Advair, Drugs, Patent

First reported May 13 2013 - Updated May 14 2013 - 2 reports

Theravance Inc

Theravance, Glaxo, Elan Star In Biotech Soap Opera

Posted 05:30 PM ETShares of small biotech Theravance (THRX) hit an all-time high on Monday, rising 18%, as the company took a central role in a drama involving drug companies with very different agendas.Early Monday, Theravance announced that Irish drugmaker ... [Published Investors Business Daily - May 13 2013]

Entities: Theravance Inc, GlaxoSmithKline plc, BREO (Drug), Advair

First reported May 10 2013 - Updated May 11 2013 - 3 reports

GSK adds competitor to COPD market

The FDA's Friday approval of GlaxoSmithKline's drug Breo just made the COPD therapy market more crowded, and GSK's marketing strategy more complex.The regulator's approval of the once-a-day medication follows an advisory committee's April 17 thumbs-up ... [Published Medical Marketing And Media - May 11 2013]

Entities: GlaxoSmithKline plc, Chronic Obstructive Pulmonary Disease, BREO (Drug), Drugs

First reported May 10 2013 - Updated May 10 2013 - 3 reports

GlaxoSmithKline plc

FDA approves once-a-day inhaler from Glaxo

Glaxo, a leader in respiratory medicine, already sells the asthma treatment Advair, its best-selling product with more than $4 billion in sales per year. The British drugmaker collaborated on the inhaler with South San Francisco-based Theravance. ... [Published Modesto Bee - May 10 2013]

Entities: GlaxoSmithKline plc, Theravance Inc, Advair

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Can't afford your prescription? The drug maker may be able to help: The Frugal Patient

Rules differ for each company, but generally you'll need to fill out an application, available online; provide proof of income; have a prescription from your doctor; and have your doctor sign the application.(By the way, I've checked out a few of the ... [Published Cleveland Live - May 08 2013]

Entities: Drugs, Patient, Symbicort, Advair, Zantac

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Tamiflu Leads Q1 Drug Sales Growth

In the first quarter of 2013, the rankings for the top five drugs by sales shifted a bit, but exhibited positive growth for the quarter, according to a report released by Drugs.com. Abilify, Otsuka's second generation antipsychotic, and Nexium, AstraZeneca's ... [Published Pharmaceutical Technology - May 07 2013]

Entities: Tamiflu, Drugs, Avonex, Modafinil, Abilify

First reported May 06 2013 - Updated May 06 2013 - 2 reports

Rough U.S. Flu Season Boosts Numbers for Tamiflu

Posted in News, Tamiflu, Influenza, Seasonal InfluenzaDrugs.com, a leading online clinical drug resource, today released first quarter 2013 U.S. prescription sales data for the top 100 drugs. The top five drugs have minor shifts in rank but exhibit ... [Published Infection Control Today - May 06 2013]

Entities: Tamiflu, Influenza, Cymbalta, Drugs

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Inhalation & Nasal Spray Generic Drugs 2012

It is no surprise then, that such high revenue originator drugs are attracting interest from prospective generic competitors. Unlike the oral generics market, however, where numerous companies typically compete for a revenue share, relatively few companies ... [Published Research and Markets - May 01 2013]

Entities: Inhalation, Seretide, Advair

First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Buy These Patent-Cliff Proof Stocks

Madhu is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.Patent expiration is one of the major issues faced by pharma companies, which increases the competition from generic ... [Published Motley Fool - Apr 29 2013]

Entities: Drugs, Advair, Patent, Sutent, BREO (Drug)

First reported Apr 17 2013 - Updated Apr 18 2013 - 8 reports

New GlaxoSmithKline lung drug nabs thumbs-up from FDA experts

An FDA advisory panel gave an approval stamp to GlaxoSmithKline's ($GSK) new lung drug, Breo. The agency advisers weren't unanimous in backing GSK's follow-up to now-off-patent Advair, however; some expressed reservations about Breo's ability to reduce ... [Published FiercePharma - Apr 18 2013]

Entities: GlaxoSmithKline plc, BREO (Drug), Drugs

Quotes

"Phase III data indicate that indacaterol/glycopyrronium has a strong efficacy profile," said Decision Resources Analyst Amanda Puffer. "Thought leaders are enthusiastic about the LABA/LAMA products and expect them to provide greater efficacy compared with individual current therapies. Based on lung function data and improvements in quality of life, indacaterol/glycopyrronium has advantages over both Spiriva and Advair. But the market is expected to be crowded, so we are conservative in our expected uptake of indacaterol/glycopyrronium."

Survey indicates improved effect on quality of life is one of the greatest unmet needs of COPD pa ... [Published Pro Health Service Zone - May 22 2013]

...the time is right to have that discussion about whether the patents are working, and whether they're necessary for drug discovery," Todd said. "I want to hear on from people from on both sides. I think we just have to have that conversation."

How Property Rights Keep Medicine Out of Reach [Published Atlantic Monthly - May 15 2013]

More Content

sort by: Date \| Relevance
To Your Good Health: Are asthma meds, high bloo... [Published Herald & Review - May 25 2013]
Asthma meds tied to high blood pressure? [Published Detroit News - May 24 2013]
Five arrested for selling drugs, guns out of ne... [Published Brooklyn Daily Eagle - May 23 2013]
3 Reasons to Love GlaxoSmithKline [Published Motley Fool - May 22 2013]
Survey indicates improved effect on quality of ... [Published Pro Health Service Zone - May 22 2013]
Regeneron Eyes Potential Blockbuster With Asthm... [Published Xconomy - May 22 2013]
Three Reasons To Love GlaxoSmithKline Plc [Published Motley Fool UK - May 21 2013]
Teva Bets on Reformulating Old Drugs as Investo... [Published La Repubblica - May 20 2013]
Crime rate drops [Published Kelowna Daily Courier - May 17 2013]
Industry dynamics such as patent cliff will imp... [Published PharmaBiz - May 17 2013]
Concerned about GMOs [Published Kelowna Daily Courier - May 16 2013]
Jennifer L. Lemke-Rude [Published Ozaukee Press - May 16 2013]
Ed Burmeister [Published Ozaukee Press - May 16 2013]
Tyler Bares [Published Ozaukee Press - May 16 2013]
Theravance's CEO Presents at Bank of America Me... [Published Seeking Alpha - May 16 2013]
AMD Recognizes Exemplary Performance of Seven S... [Published AMD Zone - May 15 2013]
AMD Expands Never Settle Bundle Crysis 3 and To... [Published AMD Zone - May 15 2013]
Mylan: Solid Results Despite Revenue Miss [Published Seeking Alpha - May 15 2013]
How Property Rights Keep Medicine Out of Reach [Published Atlantic Monthly - May 15 2013]
Council tells residents ditches are up to them [Published Kelowna Daily Courier - May 15 2013]
Local candidates make one last push for votes [Published Kelowna Daily Courier - May 14 2013]
Research and Markets Offers Report: Inhalation ... [Published Pharmacy Choice - May 14 2013]
Elan deal may be medicine to calm acquisition n... [Published BDlive - May 14 2013]
Theravance, Glaxo, Elan Star In Biotech Soap Opera [Published Investors Business Daily - May 13 2013]
FDA cleared requests of THERAVANCE & GSK for CO... [Published Equities.com - May 13 2013]
Why Did This Biotech Soar? [Published Motley Fool - May 13 2013]
Elan makes $1 billion drug royalty deal to defe... [Published MedCity News - May 13 2013]
Elan's $1 billion drug royalty deal aids bid de... [Published Yahoo! News - May 13 2013]
Elan's $1 billion drug royalty deal aids bid de... [Published 92.9 WLMI - May 13 2013]
Elan buys into GSK-partnered Theravance program... [Published PMLive - May 13 2013]

Blogs

sort by: Date \| Relevance
Pharma Spent Less $$ Last Year To Promote Drugs [Published Pharmalot - Mar 01 2013] In 2012, more than $27 billion was spent by the pharmaceutical industry in the US to promote medicines, which amounted to an 8 percent drop from the previous year. Some things, however, stayed the same. The share of the top therapeutic classes by spending ...
Cymbalta still tops in U.S. drug promotion list [Published Medad Blog - Feb 28 2013] The 10 most promoted drugs in the United States in 2012 were Cymbalta, Celebrex, Advair, Crestor, Pradaxa, Cialis, Bystolic, Symbicort, Viibryd, and Spiriva, according to Cegedim Strategic Data’s “2012 U.S . Pharmaceutical Spending Report.” Companies ...
Hey GSK - what's a weekend boondoggle? [Published PharmaGossip - Feb 07 2013] Louisiana attorney general files second suit against GlaxoSmithKline over off-label drug useGlaxoSmithKline allegedly marketed nine drugs illegally for uses that have not been approved by the Food and Drug Administration and provided doctors with "consulting ...
Fatster’s Roundup [Published Firedoglake - Jan 02 2013] Happy New Year! International Developments ❖ “ The UN Security Council has imposed sanctions against leaders of the M23 rebel movement in DR Congo.” Assets have been frozen, including those of allies in Rwanda. ❖ “Syria unrest: Fierce clashes ...
Advair and the long acting beta agonist paradox [Published KevinMD.com - Dec 24 2012] The long-acting beta agonist (LABA) paradox strikes again. A new article in a Milwaukee newspaper sounds an old theme. Advair, the most widely used asthma medicine, contains a long-acting beta agonist—salmeterol. “[L]ong-acting beta-agonists have ...

Press Releases

sort by: Date \| Relevance
Research and Markets: Inhalation & Nasal Spray ... [Published Business Wire - May 02 2013]